Biotech
LONDON, ONTARIO: LONDON, ONTARIO -- (Marketwire) -- 04/27/12 -- Critical Outcome Technologies Inc. (TSX VENTURE: COT) ("COTI" or the "Corporation") is pleased to announce that it completed the fi ...
BERKELEY, CA: BERKELEY, CA -- (Marketwire) -- 04/27/12 -- Dynavax Technologies Corporation (NASDAQ: DVAX) today reported financial results for the first quarter ended March 31, 2012, including $106.9 million in c ...
SYDNEY, AUSTRALIA: SYDNEY, AUSTRALIA -- (Marketwire) -- 04/27/12 -- Prima BioMed (Prima) (ASX: PRR) (NASDAQ: PBMD) today released its Appendix 4C - Quarterly Report for the three month period ending 31 March 2012.The ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwire) -- 04/27/12 -- Trimel Pharmaceuticals Corporation (TSX: TRL) (the "Company" or "Trimel") today announced the completion of the treatment phase of ...
LAVAL, QUEBEC, CANADA: LAVAL, QUEBEC, CANADA -- (Marketwire) -- 04/26/12 -- ProMetic Life Sciences Inc. (TSX: PLI) ("ProMetic" or the "Corporation") announced today the execution of private placements ...
BERKELEY, CA: BERKELEY, CA -- (Marketwire) -- 04/26/12 -- Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that it has submitted a U.S. Biologics License Application (BLA) to the Food and Drug Admi ...
SOUTH SAN FRANCISCO, CA: Company Reviews Recent Advancements in Its Skeletal and Cardiac Muscle Contractility Programs ...
ZWINGENBERG, GERMANY: Immortalized Human Taste Cell Lines Provide New Insights Into Taste Reception and Help Improve Nutraceutical Development ...
MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwire) -- 04/26/12 -- Paladin Labs Inc. (TSX: PLB), a leading Canadian specialty pharmaceutical company, will release its first quarter 2012 financial results on Thursday, ...
TUSTIN, CA: Global Experts Convene to Discuss Innovative Science and Applications of Targeting Phosphatidylserine; Philip Thorpe, PhD, to Discuss Peregrine's Lead Drug Candidate, Bavituximab ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwire) -- 04/26/12 -- Stem Cell Therapeutics Corp. (TSX VENTURE: SSS) ("SCT" or the "Company") a life sciences development company of stem cell-related ...
SOUTH SAN FRANCISCO, CA: Safety and Tolerability of CK-2017357 in These Two Trials Support Progression to Registration Stage Program ...
BOSTON, MA: The Business of Invention: Patenting for Biotechs ...
LAVAL, QUEBEC, CANADA: LAVAL, QUEBEC, CANADA -- (Marketwire) -- 04/25/12 -- ProMetic Life Sciences Inc. (TSX: PLI) ("ProMetic"or the "Corporation") announced today that it has received a $1.9 million f ...
BOSTON, MA: BGI's EasyGenomics Service Brings Era of Affordable, Personalized Medicine a Step Closer to Reality ...
BOTHELL, WA: Previously Reported Data Demonstrated Study Met Primary Endpoint ...
PARSIPPANY, NJ: Quarterly Net Revenues Rise 12.9% to $126.6 Million ...
PRINCETON, NJ: Data Includes Results From Comparative Phase III Study ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 04/25/12 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced the appointment of Robert Simon as Senior Vice President of Regulatory Affairs. ...
